Patent: 10,287,294
✉ Email this page to a colleague
Summary for Patent: 10,287,294
Title: | Compounds for use in treating or preventing cancerous diseases |
Abstract: | The invention relates to new compounds of formula (I) that are useful in medicine, specifically in treating or preventing cancerous diseases in a mammal, to pharmaceutical compositions comprising such compounds, optionally together with other pharmaceutically active compounds, or to pharmaceutical formulations comprising such compounds or pharmaceutical compositions. The invention further relates to methods of making these compounds. |
Inventor(s): | Stellas; Dimitris (Athens, GR), Tamvakopoulos; Constantin (Athens, GR), Klinakis; Apostolos (Iraklio, GR), Efstratiadis; Argiris (Athens, GR), Cournia; Zoe (Kifissia, GR) |
Assignee: | BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS (GR) |
Application Number: | 15/742,330 |
Patent Claims: | see list of patent claims |
Details for Patent 10,287,294
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2035-07-08 |
Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2035-07-08 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2035-07-08 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2035-07-08 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2035-07-08 | |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2035-07-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |